GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Microport Cardioflow Medtech 2160.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2024

Revenue

CN¥361.6m

FY2018FY2024

Net income

−CN¥49.4m

FY2018FY2024

Free cash flow

−CN¥270.1m

FY2018FY2024

Shareholders' equity

CN¥2.19bn

FY2018FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueCN¥361.6mCN¥336.2mCN¥251.0mCN¥200.8mCN¥103.9mCN¥21.5m—
Research and developmentCN¥153.4mCN¥237.3mCN¥223.8mCN¥151.1mCN¥96.8mCN¥96.7mCN¥44.7m
Operating income−CN¥159.5m−CN¥351.7m−CN¥330.2m−CN¥197.3m−CN¥138.9m−CN¥124.5m−CN¥59.9m
Net income−CN¥49.4m−CN¥471.5m−CN¥454.4m−CN¥183.3m−CN¥398.1m−CN¥144.5m−CN¥60.3m
Diluted earnings per share-0.10-0.99-0.96-0.39-1.16-0.41-0.18

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsCN¥2.68bnCN¥2.58bnCN¥3.00bnCN¥3.36bnCN¥1.11bnCN¥545.9mCN¥402.1m
Cash and short-term investmentsCN¥1.36bnCN¥1.77bnCN¥2.08bnCN¥2.40bnCN¥612.8mCN¥109.6mCN¥50.7m
Total liabilitiesCN¥488.6mCN¥242.2mCN¥247.5mCN¥265.5mCN¥1.46bnCN¥414.1mCN¥128.8m
DebtCN¥76.9mCN¥70.5mCN¥95.5mCN¥125.6mCN¥15.8mCN¥38.6mCN¥16.3m
Shareholders' equityCN¥2.19bnCN¥2.33bnCN¥2.75bnCN¥3.10bn−CN¥345.2mCN¥131.8mCN¥273.4m
Shares outstanding468m473m473m466m343m350m334m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−CN¥111.7m−CN¥207.0m−CN¥182.5m−CN¥161.5m−CN¥109.8m−CN¥142.7m−CN¥70.2m
Capital spending−CN¥158.4m−CN¥30.5m−CN¥49.1m−CN¥108.4m−CN¥58.2m−CN¥48.7m−CN¥65.5m
Free cash flow−CN¥270.1m−CN¥237.5m−CN¥231.6m−CN¥269.9m−CN¥168.0m−CN¥191.4m−CN¥135.7m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueCN¥229.1mCN¥138.4mCN¥223.1mCN¥159.8mCN¥176.4mCN¥126.2mCN¥124.8mCN¥114.6m
Operating income−CN¥31.2m−CN¥90.5m−CN¥69.1m−CN¥205.7m−CN¥145.9m−CN¥215.4m−CN¥114.8m−CN¥142.6m
Net income−CN¥2.2mCN¥7.0m−CN¥56.5m−CN¥292.1m−CN¥179.4m−CN¥332.0m−CN¥122.4m−CN¥113.2m
Diluted earnings per share-0.000.00-0.12-0.61-0.37-0.70-0.25-0.23
Cash from operations−CN¥15.0m−CN¥26.0m−CN¥84.0m−CN¥81.0m−CN¥125.0m−CN¥100.0m−CN¥82.0m−CN¥117.0m
Capital spending−CN¥230.0m−CN¥152.0m−CN¥5.0m−CN¥9.0m−CN¥20.0m−CN¥16.0m−CN¥32.0m−CN¥77.0m
Free cash flow−CN¥245.0m−CN¥178.0m−CN¥89.0m−CN¥90.0m−CN¥145.0m−CN¥116.0m−CN¥114.0m−CN¥194.0m
Total assetsCN¥2.67bnCN¥2.68bnCN¥2.50bnCN¥2.58bnCN¥2.90bnCN¥3.00bnCN¥3.22bnCN¥3.36bn
Cash and short-term investmentsCN¥1.32bnCN¥1.36bnCN¥1.56bnCN¥1.77bnCN¥2.00bnCN¥1.87bnCN¥2.14bnCN¥2.40bn
DebtCN¥199.8mCN¥13.8mCN¥44.1mCN¥41.9mCN¥54.2mCN¥64.4mCN¥76.7mCN¥90.9m
Shareholders' equityCN¥2.18bnCN¥2.19bnCN¥2.16bnCN¥2.33bnCN¥2.66bnCN¥2.75bnCN¥2.99bnCN¥3.10bn

Financial ratios

Data as of 20 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-34.5%-38.1%-136.7%-145.7%-89.5%-242.4%
Net margin-33.0%-13.7%-140.2%-181.0%-91.3%-383.0%
Return on equity-7.3%-2.3%-20.2%-16.5%-5.9%115.3%
Return on assets-2.8%-1.8%-18.3%-15.1%-5.5%-35.8%
Free cash flow yield39.1%1.1%-4.1%-3.2%-1.4%-1.8%
Revenue growth796.2%4.3%29.5%16.3%98.1%410.4%
Earnings growth2061.9%-89.8%0.3%130.6%-52.8%190.9%
Current ratio2.52x3.80x10.55x12.82x15.81x0.50x
Debt to equity0.19x0.04x0.02x0.01x0.01x-0.02x
Equity ratio38.3%81.7%90.6%91.8%92.1%-31.0%
Interest coverage-89.57x-36.52x-117.41x-70.52x-9.16x-1.72x
R&D as a share of sales25.4%42.4%70.6%89.1%75.3%93.2%
Buybacks as a share of market value-5.6%1.5%-0.3%1.8%-41.5%-133860.7%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.7%75.8%—
Operating income-6.8%5.1%—
Net income-35.4%-19.3%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-73.3%-90.4%-102.1%—
Net margin-74.7%-100.8%-133.4%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021
Price to earnings-5.7-1.4-2.4-8.7
Price to sales0.82.04.37.9

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-to-1 reverse split · 24 Feb 2026

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.